72
Participants
Start Date
May 1, 2026
Primary Completion Date
March 1, 2028
Study Completion Date
October 1, 2028
pBI-11
HPV16/18 vaccine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER